Kazia Therapeutics Ltd

KZIA chart

Kazia Therapeutics Ltd news

• Kazia Therapeutics Ltd (NV9.DE) Seasonal returns chart - Yahoo Finance

  Yahoo Finance Singapore · Nov 5, 8:22 AM EST

• Kazia Therapeutics Recognized as "Drug Discovery Company of the Year" in 2026 BioTech Breakthrough Awards

  Yahoo Finance · Nov 5, 7:00 AM EST

• Kazia Therapeutics Announces Two Abstracts on Paxalisib Tumor and Immune Reprogramming Research Accepted for Poster Presentation at 2026 San Antonio Breast Cancer Symposium

  Yahoo Finance · Nov 2, 7:00 AM EST

• Reddit downgraded, Rivian upgraded: Wall Street's top analyst calls

  Yahoo Finance · Oct 30, 9:45 AM EDT

• Kazia Therapeutics to Participate in Fireside Chat at Guggenheim 3rd Annual Healthcare Innovation Conference

  Yahoo Finance · Oct 29, 7:00 AM EDT

• Kazia Therapeutics Announces Sovargen Co. Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders

  Yahoo Finance · Sep 22, 7:30 AM EDT

• Bank of New York Mellon Corporation (BNY) Lost A Depositary Mandate

  Yahoo Finance · Sep 19, 6:15 PM EDT

• Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer

  Yahoo Finance · Sep 9, 7:30 AM EDT

• Kazia (KZIA) Raises Approximately $40M in Gross Proceeds and Expands Paxalisib. Is the Capital Base Stronger than the Clinical Evidence?

  Yahoo Finance · Sep 9, 12:05 AM EDT

• Kazia Therapeutics Reports Preclinical Tumor Reduction in Colorectal Cancer Study

  Yahoo Finance · Sep 1, 8:30 AM EDT

• Kazia Therapeutics Reports Preclinical Data Showing Paxalisib Reprograms Immunotherapy-Resistant MSS/pMMR Colorectal Cancer and Enhances Response to Immunotherapy

  Yahoo Finance · Sep 1, 7:30 AM EDT

Kazia Therapeutics Ltd key financials

No XBRL financial data is available for this company yet.

Calendar-year figures as reported to the SEC in XBRL filings.

Recent SEC filings

• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-22
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-18
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-09-01
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-31
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-31
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-28
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-08-27
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-07-28
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-06-02
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-05-26
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-04-27
• 6-KREPORT OF FOREIGN PRIVATE ISSUER2026-04-15

About Kazia Therapeutics Ltd

Ticker

KZIA (Nasdaq)

Industry

Pharmaceutical Preparations

Headquarters

Sydney Nsw

Incorporated in

Australia

Fiscal year end

June 30

SEC CIK

1075880

Former names

NOVOGEN LTD

Frequently asked questions